Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.
Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. · 2018
Read Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion. by Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5945880.txt.
Introduction
Castro and co-authors review interferon-gamma at the crossroads of tumour immune surveillance and evasion. Their review appeared in Frontiers in Immunology. Interferon-gamma is a cytokine with antiproliferative and pro-apoptotic effects. It is often seen as a major effector of antitumour immunity. Yet therapies based on it have had limited success. Reports now suggest it can also help tumours.
Tumours may stop responding to its signals, the authors note. They may lower their major histocompatibility complexes to hide. They may raise checkpoint molecules such as PD-L1. Still, interferon-gamma responses track with better survival in several cancers. The review argues for finding which patients will respond.
Catalog record
| CREATOR | Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. |
|---|---|
| YEAR | 2018 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 116 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |